•
IN
INO
Inovio Pharmaceuticals, Inc.
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
103.74M
Volume
747.76K
52W High
$2.98
52W Low
$1.30
Open
$0.00
Prev Close
$1.51
Day Range
0.00 - 0.00
About Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Latest News
Arch Therapeutics Inc. (ARTH) Product Pipeline Analysis, 2025 Update
GlobeNewswire Inc.•Aug 8
Cancer Vaccine Market Research Service Featuring the Top 5 Developers and Pipeline Activities - OncoTherapy Science, Inovio, BioNTech, Theravectys, and GlaxoSmithKline
GlobeNewswire Inc.•Jul 30
Better Buy: Inovio Pharmaceuticals vs. Novavax
The Motley Fool•May 22
DNA Medicine Focused INOVIO Pharma Efficiencies Implemented By Leadership Will Help De-Risk Its Platform Technology: Analyst
Benzinga•May 14
Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
The Motley Fool•May 14
Equillium, Inc. (EQ) Reports Q1 Loss, Tops Revenue Estimates
Zacks Investment Research•May 9
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
The Motley Fool•May 5
Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga•Apr 16